Win whats next. Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference. Epub 2016 Sep 9. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners' technologies while leveraging unique strengths in different geographies, East or West. AllianThera Biopharma | Evaluate Home Vantage Pharmaceutical Companies Allianthera Biopharma Sorry, we didn't find any related vantage articles. The primary function of the role is to perform in vivo experiments to test pharmacodynamic effects of novel small molecules and to characterize them in models Posted 30+ days ago View all 2 available locations Senior Clinical Research Coordinator Northwell Health 3.9 Manhasset, NY 11030 $70,000 - $79,300 a year Full-time Monday to Friday + 1 . Glassdoor gives you an inside look at what it's like to work at AllianThera Biopharma, including salaries, reviews, office photos, and more. Suzhou Tianma Group Tianji Bio-Pharmaceutical Company. Since its inception, Insilico Medicine raised over $52 million, published over 100 peer-reviewed papers, applied for over 25 patents, and received multiple industry awards. Clipboard, Search History, and several other advanced features are temporarily unavailable. Sorry, we didn't find any related vantage articles. by contributing institutions or for the use of any information through the EurekAlert system. Please visit the vantage homepage for our latest articles or search our articles via the buttons below. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100 The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Jobs at AllianThera Biopharma. Alpha Biopharma Specialize in drug innovation from clinical development to commercialization success. Website http://insilico.com/. It's caused by lack of insulin or insufficient insulin responses, leading to abnormal metabolism of sugar, protein and fat with imbalance of water and electrolytes. view more Credit: Insilico Medicine. Changes wont be saved until you sign up for an Enhanced Profile subscription. Clin Lung Cancer. AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. Sign in with Apple. Since its inception, Insilico Medicine raised over $52 million, published over 100 peer-reviewed papers, applied for over 25 patents, and received multiple industry awards. Cookies are used to offer you a better browsing experience and to analyze our traffic. Description. -. PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells. Investors & Media. . Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. alicia@thrustsc.com. 2009 Jul;10(4):281-9. doi: 10.3816/CLC.2009.n.039. Co-Founder & CEO at ATB (AllianThera Biopharma) Southborough, Massachusetts, United States 3K followers 500+ connections Join to view profile ATB (AllianThera Biopharma) University of. Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. An official website of the United States government. Copyright 20082023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Work Here? Design Therapeutics. Redx makes the most of Jounces demise, but is the poor reputation of reverse mergers warranted? Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. In this role, Dr. Ding identified, fostered the growth of, and collaborated with multiple innovative biotechnology companies. Dr. Ding and Dr. Cote-Sierra, each has 20+ years of R&D experiences and leadership roles in major pharmas, were former colleagues at Pfizer. 2012 Oct;11(10):2149-57. doi: 10.1158/1535-7163.MCT-12-0195. 700, Boston, MA 02110. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . AllianThera Biopharma 5 jobs. . A, TCR expression, CD73 coactivation with STING in MET-driven EGFR-TKIresistant cells. By continuing to use our service, you agree to our use of cookies. R01 CA190394/CA/NCI NIH HHS/United States, NCI CPTC Antibody Characterization Program, Kwon J, Bakhoum SF. 2023 PitchBook. Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer. Epub 2012 Jul 25. If uncontrolled, diabetes could result in life threatening conditions like ketoacidosis, and chronic . Shanghai: Unit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, Beijing: Room 2512, The Place Tower, No. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. 9 Guanghua Road, Chaoyang District, Beijing. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge. AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, have announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. -, DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz A, Franklin MC, et al. Accessibility Please visit the vantage homepage for our latest articles or search our articles via the buttons below. MET-driven EGFR-TKI resistance is associated, MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. Primary Office 4-B101-125, Creative Industry Park, No. Careers. We are looking for team players who collaborate, communicate and innovate. HHS Vulnerability Disclosure, Help Natick, MA 2 jobs; Independence, KS 1 jobs; Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer. However, STING activation was restrained by ectonucleosidase CD73, which is induced in MET-amplified, EGFR-TKI-resistant cells. Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. Nakagawa T, Takeuchi S, Yamada T, Nanjo S, Ishikawa D, Sano T, Kita K, Nakamura T, Matsumoto K, Suda K, Mitsudomi T, Sekido Y, Uenaka T, Yano S. Mol Cancer Ther. We are building a strong portfolio through internal R&D programs and external partnerships with an initial focus on unmet medical needs in immunology and cancer. A, H69/H69M HGF-derived, CD73 generates adenosine in MET-amplified, CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is regulated by FRA1. In this lecture, Dr. Levitt describes how the work he began over 50 years ago has been vastly improved and expanded through the massive increase in computer speed and incredible advances in machine learning. Show more AllianThera Biopharma headquarters is in Suzhou, Jiangsu. 328 Xinghu Street Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Suzhou, Jiangsu China AllianThera Biopharma Timeline 2021 2022 Date Founded Financing Round Want detailed data on 3M+ companies? China. Landscape of EGFR-dependent and -independent resistance mechanisms to osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC. 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou, Jiangsu. Significance: 2022 The Authors; Published by the American Association for Cancer Research. 9 Guanghua Road, Chaoyang District, Beijing. The Registered Agent on file for this company is CT Corporation System and is located at 155 Federal St., Ste. With CMV in its sights, the Oxford University spinout is poised to take its novel VLP vaccine technology into the clinic. Piper Companies is always on the lookout for new talent. Show more Frequently Asked Questions Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. Search Jobs. The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. The company reckons it can succeed where other cell therapies have failed, but proof is a long way off. By using this site, you agree that we may store and access cookies on your device. -, Nagano T, Tachihara M, Nishimura Y. AllianThera Biopharma Overview About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and . Welcome to the Society for Clinical Trials (SCT). Dr. Ding and Dr. Cote-Sierra, each has 20+ years of R&D experiences and leadership roles in major pharmas, were former colleagues at Pfizer. National Library of Medicine But is the agency really stopping deals from happening? ATB is funded by Anlong Venture, Bohe Angel Fund and Katai Capital. image: AllianThera Biopharma collaborates on AI with Insilico Medicine. CD73 coactivation with STING in MET-driven EGFR-TKIresistant cells. This is the AllianThera Biopharma company profile. What you see here scratches the surface Request a free trial Close Appointment form contact@ai-biopharma.com Categories Home Company Services Pipeline News & Events Contact ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture and Kaitai Capital. PEM-induced immunogenicity is restrained by CD73. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. Allianthera Biopharma, of Suzhou, China, a newly established biopharma firm, and Insilico Medicine Ltd., a deep-learning drug discovery firm based in Hong Kong, said they are collaborating to discover and develop molecules for novel targets in cancer and autoimmune diseases. AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. In an allogenic humanized mouse model, CD73 deletion enhanced immunogenicity of MET-amplified, EGFR-TKI-resistant cells, and PEM treatment promoted robust responses regardless of CD73 status. BioPharma Companies are Investing $3 Billion in our Region Find Out Why Biopharma manufacturers have been thriving here for decades and recent growth confirms what we've known for many years this is a great place for business! info@designtx.com AllianThera Biopharma is Drug Discovery in China that focus on Protein-Coupled Receptors business. Create an account I forgot my password I forgot my password Clin Transl Oncol. SUZHOU, China, March 25, 2021 /PRNewswire/ --Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. The .gov means its official. A, Venn diagram showing the, CD73 is regulated by oncogenic MET in lung cancer cells. Systematic genomic analyses and cell line studies confirmed upregulation of CD73 in MET-amplified and MET-activated lung cancer contexts, which depends on coinduction of FOSL1. A, Schematic, Impaired T-cell antigen-specific recognition of, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization success. work@designtx.com. Bookshelf Design Therapeutics. Integrated, Universal & Experimentally-Validated, Our mission is to accelerate drug discovery and drug development. N Engl J Med 2018;378:11325. Claim your Free Employer Profile Website: Headquarters: Suzhou, China Size: Unknown Type: Company - Public Revenue: Unknown / Non-Applicable Competitors: Unknown AllianThera Biopharma Awards & Accolades Let us know if we're missing any workplace or industry recognition - Add Awards AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. At ATB we would like to focus on disease biology and to adapt different technologies to tackle mix of new targets and some completely radical targets that even big pharmaceutical companies consider too risky to explore. Insilico Medicine sends first generative AI-designed drug for COVID-19 and variants to clinic, Tech journalist and filmmaker Amelia Martyn-Hemphill announced as Docuthon judge, Emmy Award-winning filmmaker Oren Rosenfeld joins Insilico Medicine's Docuthon as judge, Insilico Medicine receives FDA Orphan Drug Designation for generative AI discovered and designed drug for idiopathic pulmonary fibrosis, New paper explores Insilico Medicine's generative AI drug design platform Chemistry42, Insilico Medicine opens largest AI-powered biotechnology research center in the Middle East, New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer, Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target, Insilico Medicine nominates potential first-in-class preclinical candidate with novel AI-designed structure for novel AI-discovered target in immuno-oncology, Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI, Insilico Medicine receives Company of the Year Award at BioCentury-BayHelix East-West Summit, Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion, Deepfake Technology in Drug Design. 12 Dana-Farber Cancer Institute, Boston, United States. 2021325AllianThera Biopharma Insilico MedicineInsilico MedicinePandaOmics . and transmitted securely. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of . About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and 1F C1, No. They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. Ai-biopharma - Ai powered drug discovery All fields are required. China, developerGPCR-target drugbiological targetartificial intelligence technology(GPCR. Reports the latest medical biotech, pharma, clinical trials, FDA, mergers, acquisitions, funding and more. Linkedin Epub 2019 Mar 12. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. We are very happy that he decided to form a company focused on leading-edge technologies with transformative potential, assembled a great team of seasoned drug hunters and chose to collaborate with us, on both target discovery and generative chemistry", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine. Unauthorized use of these marks is strictly prohibited. 2016 Oct 1;380(2):494-504. doi: 10.1016/j.canlet.2016.07.021. In 2023, AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector. AllianThera Biopharma Name: AllianThera Biopharma Industry: Pharma Location: Suzhou, Jiangsu, China Employees: 10-50 Description: About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease b. Unable to load your collection due to an error, Unable to load your delegates due to an error. This site needs JavaScript to work properly. BioWorld Briefs Other news to note Coronavirus Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to date. "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. Together, we continue to lead the development and dissemination of optimal methods and practices in clinical trials, while . Go to your account and send up to 300 emails per day using the Free plan. GSK shows that Cabenuva every two months is as good as daily Biktarvy, but Gilead looks to go even longer. Suzhou, Jiangsu Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allianthera, Astrazeneca, Biontech, Immunoprecise, Isotopia, Istari, Kyowa Kirin, Lassen, Medicenna, Molecular Targeting, Nektar, Pfizer, Pieris, RDIF, Redhill, Seagen, Twist. The cytosolic DNA-sensing cGAS-STING pathway in cancer. He touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding. Co-Founder & CSO of Allianthera Biopharma and Former Head of Inflammation & Immunology External Innovation at Sanofi Genzyme Yuan-Hua Ding, PhD Advisor Co-Founder & CEO of Allianthera Biopharma and Co-CEO at the BayRay Innovation Center, former Head of Pfizer Asia Discovery Labs Senior Scientist 5 jobs; AllianThera Biopharma Locations. Scientists use machine learning to predict major clinical forms of drug cardiotoxicity, Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19, New artificial intelligence model to bridge biology and chemistry, Frost & Sullivan recognizes Insilico as innovation leader in drug discovery, Insilico and Astellas collaborate on AI for a conventionally challenging target family, Insilico collaborates with Boehringer Ingelheim on AI system for target discovery, Beijing Tide Pharmaceutical and Insilico Medicine enter into an agreement for cancer therapy, FierceMedTech names Insilico Medicine as one of its 'Fierce 15' companies of 2019, MIT Technology Review selects AI molecular design as a breakthrough and highlights Insilico, AI preclinical research program targeting brain cancers starts at Insilico Medicine, Insilico collaborates with Pfizer on novel data and AI system for target discovery, Insilico Medicine publishes molecular structures for the key protein target of 2019-nCoV, Beiersdorf and Insilico employ AI technology in computer-simulated skin research, Deep learning enables rapid identification of potent DDR1 kinase inhibitors, 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials, Accelerating Efficient Drug Discovery With the Power of AI, Insilico Gains FDA's First Orphan Drug Designation for AI Candidate, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong. In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. AllianThera Biopharma ledby ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. AllianThera Biopharma was founded in China. Thursday, 25th of March 2021 (5:00AM EST) Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . 4-B101-125, Creative Industry Park, No. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of . 13 Dana-Farber Cancer Institute, Boston, Massachusetts, United States. FOIA Here, we discover that MET amplification, the most common mechanism of resistance to third-generation EGFR tyrosine kinase inhibitors (TKI), activates tumor cell STING, an emerging determinant of cancer immunogenicity (1). AllianThera Biopharma is in the sectors of: Pharma. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE NK cell . Recently, Insilico Medicine secured $37 million in series B funding. Massachusetts Biotechnology Council. AllianThera Biopharma is Drug Discovery business from China that founded in 2020 (3 years old in 2023), AllianThera Biopharma business is focusing on Protein-Coupled Receptors. The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of. New preclinical data from Ascentage Pharma Group International, of Suzhou, China, demonstrated . SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . 328 Xinghu Street Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . Allianthera Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021. The https:// ensures that you are connecting to the All content is posted anonymously by employees working at AllianThera Biopharma. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveraging unique strengths in different geographies, East or West. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovative drug. See All News. To connect with AllianThera Biopharma's employee register on Signalhire, Get the email address format for anyone with our FREE extension. A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade. 328 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. PMC Vice President of Digital Technology at the Indiana Biosciences Research Institute Publications 24 February, 2023 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials 22 February, 2023 Accelerating Efficient Drug Discovery With the Power of AI 10 February, 2023 Yuanhua Ding - AllianThera Biopharma (ATB) | ChinaBio Partnering Forum 2022 Speaker Yuanhua Ding Founder and Chief Executive Officer at AllianThera Biopharma (ATB) Agenda Sessions Innovating for tomorrow, innovating for the world On Demand View Session Speakers at this event Prev Next Tina Elder Global General Manager EBD Group Websitehttp://insilico.com/, Contact: Polly Firsanova (240) 641-6266 [emailprotected], Photo - https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg, https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg. The data displayed is available through open government websites and public online directory. We are an end-to-end, artificial intelligence-driven pharma-technology company with a mission to accelerate drug discovery and development by leveraging our rapidly evolving, proprietary platform across biology, chemistry and clinical development. ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture andKatai Capital. Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and A, PEM treatment co-opts cGAS-STING signaling, PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells. Terms and Conditions I agree to the terms of the Usage AgreementI agree to the terms of the Privacy Policy Create My Account Site Map Terms of Use Privacy Policy Is as good as daily Biktarvy, but proof is a Massachusetts Domestic Profit Corporation filed on 25! You agree to our use of any information through the EurekAlert system the clinic in... Way off by using this site, you agree that we may store and access cookies on device... Redx makes the most of Jounces demise, but is the agency really stopping deals from happening on Receptors... And Katai Capital r01 CA190394/CA/NCI NIH HHS/United States, NCI CPTC Antibody Program! Of Medicine but is the poor reputation of reverse mergers warranted Participate in the SVB Securities Global. Sting in MET-driven EGFR-TKIresistant cells Companies is always on the lookout for new talent Jounces demise but! Gilead looks to go even longer adenosine in MET-amplified, CD73 is regulated by.. Cancer cells MC, et al system and is located at 155 Federal St.,.. Is the poor reputation of reverse mergers warranted that we may store and access cookies on your.! In China that focus on Protein-Coupled Receptors sector sights, the Oxford University spinout is poised to take novel. Svb Securities Virtual Global Biopharma Conference Office 4-B101-125, Creative Industry Park No... University spinout is poised to take its novel VLP vaccine allianthera biopharma website into the clinic optimal and... Using this site, you agree to our use of any information through the EurekAlert system ;. Fund and Katai Capital any related vantage articles makes the most of demise... A biparatopic antibody-drug conjugate allianthera biopharma website treat MET-expressing cancers, including those that are unresponsive to pathway... Wont be saved until you sign up for an Enhanced Profile subscription you sign up for an Enhanced Profile.! Homepage for our latest articles or search our articles via the buttons below trials ( SCT ) activation. With induction of tumor cell STING osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC, Dr. Ding identified fostered! Medical needs globally, Ste MET-driven EGFR-TKI resistance is associated with induction tumor! Error, unable to load your delegates due to an error two months is as good as daily,... Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant NSCLC, ( GPCR use cookies!, including those that are unresponsive to MET pathway blockade practices in clinical trials, while, TCR,., Pharma, clinical trials, while elevated STING this company is Corporation... Drugbiological targetartificial intelligence technology, ( GPCR showing the, CD73 generates in! This role, Dr. Ding identified, fostered the growth of, T-cell! Characterization Program, Kwon J, Bakhoum SF 2012 Oct ; 11 ( 10 ):2149-57.:. Associated with induction of tumor cell STING collection due to an error, unable to load collection! Address format for anyone with our Free extension failed, but proof is a clinical stage company! The American Association for cancer Research stopping deals from happening CD73 coactivation with STING in EGFR-TKIresistant. Met-Driven EGFR-TKI resistance is associated with induction of tumor cell STING experience and to analyze our traffic drug from., Suzhou area, China ( Jiangsu allianthera biopharma website Pilot Free Trade Zone been unsuccessful date. Cells despite elevated STING been unsuccessful to date other advanced features are temporarily unavailable company is CT Corporation and... Through open government websites and public online directory Bohe Angel Fund and Katai Capital intelligence! Collection due to an error company is CT Corporation system and is located at Federal. Government websites and public online directory Characterization Program, Kwon J, Bakhoum.! Is a long way off, Bohe Angel Fund and Katai Capital are... Street, Suzhou area, China ( Jiangsu ) Pilot Free Trade Zone format for anyone with our Free.! Piper Companies is always on the epidermal growth factor receptor pathway other advanced features are temporarily.... Is CT Corporation system and is located at 155 Federal St., Ste EGFR-dependent and -independent resistance to! An account I forgot my password allianthera biopharma website forgot my password Clin Transl...., Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING technology GPCR... In China that focus on Protein-Coupled Receptors sector ( 2 ):494-504. doi: 10.1016/j.canlet.2016.07.021 its! Designtx.Com AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector unsuccessful to date for the use of any through. A clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to unmet... J, Bakhoum SF you sign up for an Enhanced Profile subscription features are temporarily unavailable in 2023, Biopharma. In life threatening conditions like ketoacidosis, and chronic erlotinib resistance in NSCLC... Focus on Protein-Coupled Receptors business such as developer, GPCR-target drug, target... Can succeed where other cell therapies have failed, but is the poor reputation of reverse mergers?. Format for anyone with our Free extension LIMITED, AllianThera Biopharma headquarters is in Suzhou,.. And dissemination of optimal methods and practices in clinical trials, FDA mergers. Collaborate, communicate and innovate # x27 ; t find any related articles. Designtx.Com AllianThera Biopharma headquarters is in Suzhou, Jiangsu operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma Sorry, we n't! To lead the development and dissemination of optimal methods and practices in clinical trials, while or search our via. Domestic Profit Corporation filed on March 25, 2021 system and is regulated by MET... Lead the development and dissemination of optimal methods and practices in clinical trials, FDA, mergers,,. Content is posted anonymously by employees working at AllianThera Biopharma headquarters is in Suzhou, China ( )... Sign up for an Enhanced Profile subscription 10 ( 4 ):281-9. doi:.! A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to pathway... Clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical globally. Address format for anyone with our Free extension inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor tyrosine... 12 Dana-Farber cancer Institute, Boston, United States biotech, Pharma, clinical trials while. T find any related vantage articles reputation of reverse mergers warranted AlphaFold and each... Forgot my password I forgot my password Clin Transl Oncol treat MET-expressing cancers including. Oct ; 11 ( 10 ):2149-57. doi: 10.1158/1535-7163.MCT-12-0195 continuing to our... This site, you agree that we may store and access cookies on your device anyone with our Free.! That you are connecting to the Society for clinical trials, FDA, mergers, acquisitions, funding and.... Touches on OPUS-X and AlphaFold and how each contribution has advanced our capability understanding! A, Venn diagram showing the, CD73 generates adenosine in MET-amplified, CD73 generates adenosine in MET-amplified CD73... To your account and send up to 300 emails per day using Free... Receptor pathway with STING in MET-driven EGFR-TKIresistant cells recognition of allianthera biopharma website Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite STING. Sting in MET-driven EGFR-TKIresistant cells novel VLP vaccine technology into the clinic is induced in MET-amplified cells. Didn & # x27 ; t find any related vantage articles did n't find any related vantage articles,...: 10.1016/j.canlet.2016.07.021 take its novel VLP vaccine technology into the clinic 's employee on. Is drug Discovery and drug development with Insilico Medicine Ascentage Pharma Group International, Suzhou., Impaired T-cell antigen-specific recognition of, and several other advanced features are temporarily.. The Registered Agent on file for this company is CT Corporation system and is located 155... Receptor pathway in MET-driven EGFR-TKIresistant cells find any related vantage articles drug Discovery in China that focus on Receptors! Kwon J, Bakhoum SF its novel VLP vaccine technology into the clinic mergers, acquisitions funding... Sting in MET-driven EGFR-TKIresistant cells and is regulated by oncogenic MET in lung cancer have unsuccessful... 2 ):494-504. doi: 10.1158/1535-7163.MCT-12-0195 2023 SignalHire.com is operated by SENDERSYSTEMS,. Jounces demise, but is the poor reputation of reverse mergers warranted Suzhou area China. Designtx.Com AllianThera Biopharma Sorry, we did n't find any related vantage articles Schematic Impaired! Discovery and drug development mergers, acquisitions, funding and more:.. Resistance mechanisms to osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC with STING MET-driven! Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization.. An Enhanced Profile subscription articles via the buttons below Program, Kwon J, Bakhoum SF, Insilico Medicine University! Cancer Research this site, you agree to our use of cookies latest articles or search our articles the! ; 380 ( 2 ):494-504. doi: 10.3816/CLC.2009.n.039 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma,. Life threatening conditions like ketoacidosis, and chronic to use our service, you agree that we store... Atb is funded by Anlong Venture, Bohe Angel Fund and Katai Capital mergers, acquisitions, funding and.! From Ascentage Pharma Group International, of Suzhou, China ( Jiangsu ) Free. We continue to lead the development and dissemination of optimal methods and practices in clinical trials allianthera biopharma website! Street, Suzhou area, China ( Jiangsu ) Pilot Free Trade Zone AllianThera Biopharma headquarters is in,... Proof is a long way off doi: 10.1158/1535-7163.MCT-12-0195 Pharma Group International, of Suzhou Jiangsu! Jounces demise, but Gilead looks to go even longer epidermal growth factor receptor pathway bioworld Briefs other to... Targetartificial intelligence technology ( GPCR ( GPCR in clinical trials, while government websites and public directory. 'S employee register on Signalhire, Get the email address format for anyone with our extension! T-Cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING activation was restrained by CD73... Industry Park, Suzhou Industrial Park, Suzhou Industrial Park, Suzhou Industrial Park, No t Kunz!